| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_34c608ecbd415271b7346a1433cdc439 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-337
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5169
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B82Y5-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-19 |
| filingDate |
2015-07-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2020-09-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a13765feb6a107ae107363925e763a0b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_41ff24b9eaf16223c4bff5af31204393
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6fd429279dc05199c00ce849eaba6fdb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e4e1aaca1239a57269cea5fca87e39b5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c96b942ba72339cb58b7f631afdb02b4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5e7c5cac05a1e5b4f97f24c16e085e6b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3d3e3b751519d73917d45120cfc80b8c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0f2f5e950c422de2a60f8a9cf45f0320 |
| publicationDate |
2020-09-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
AU-2015283343-B2 |
| titleOfInvention |
Purified therapeutic nanoparticles and preparation methods thereof |
| abstract |
Purified therapeutic nanoparticles are provided herein. Such nanoparticles comprise an active pharmaceutical ingredient and human serum albumin, wherein the weight ratio of human serum albumin to the active ingredient in the therapeutic nanoparticles is from 0.01:1 to 1:1, and wherein the nanoparticles are substantially free of free human serum albumin that is not incorporated in the nanoparticles. The present disclosure also provides pharmaceutical compositions that comprise the purified therapeutic nanoparticles and are also substantially free of free human serum albumin. Methods for preparing and using the purified therapeutic nanoparticles and compositions thereof are also provided. |
| priorityDate |
2014-07-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |